An Open, Partly Randomised, Four-way Cross-over Study in Healthy Subjects and in Patients With Mild Allergic Asthma to Investigate the Bioavailability and Basic Pharmacokinetics of a Single Dose of AZD5423 When Administered Intravenously, Orally, Inhaled Via SPIRA Nebuliser or Inhaled Via I-neb AAD Systems.
Phase of Trial: Phase I
Latest Information Update: 26 Oct 2011
At a glance
- Drugs AZD 5423; AZD 5423; AZD 5423
- Indications Allergic asthma
- Focus Pharmacokinetics
- 26 Oct 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 26 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.